Our Viral Sensitizer technology consists of a library of over one hundred small molecules that can safely overcome the natural immunological defences in the human and animal body that suppress effective viral medicines.
When immune responses are safely reduced, targeted infection by medicinal viruses can improve. This has a number of practical and sought-out applications that positively contribute to public health goals and better clinical care.
We first identified our novel Viral Sensitizers by employing an innovative high-throughput screening process. Virica continues to employ this cutting-edge equipment and can identify the most synergistic Viral Sensitizer molecules from our library for any virus strain.